Last reviewed · How we verify
NCT03100188
Designer Dialysis Peritoneal Dialysis
NA trial testing modified PD prescription in Peritoneal Dialysis in 7 participants. Completed in 15 December 2016.
30 September 2016
Quick facts
| Lead sponsor | Louisiana State University Health Sciences Center in New Orleans |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 7 |
| Start date | 1 July 2015 |
| Primary completion | 30 September 2016 |
| Estimated completion | 15 December 2016 |
Drugs / interventions tested
- modified PD prescription
Conditions studied
- Peritoneal Dialysis — all drugs for Peritoneal Dialysis →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Who can join
18 and older, any sex, with Peritoneal Dialysis or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to use modified peritoneal dialysis prescriptions to achieve adequate clearance and volume removal while decreasing the number of exchanges or time spent on dialysis, evaluating maintenance of residual renal function, and improving quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03100188
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peritoneal Dialysis
Currently open trials in the same condition.
- NCT07098351 — Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis · NA · recruiting
- NCT07077538 — Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients · NA · recruiting
- NCT06876987 — The Mobile-based Training System in Peritoneal Dialysis Patients · NA · recruiting
- NCT06641765 — Continuous Glucose Monitoring in Dialysis Patients With Diabetes · NA · active not recruiting
- NCT06368713 — Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients · NA · recruiting
Other Louisiana State University Health Sciences Center in New Orleans trials
Trials by the same sponsor.
- NCT07462767 — Precision Microbiota Interventions for Senoreduction Trial · Phase 1, PHASE2 · not yet recruiting
- NCT07488156 — Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder · NA · not yet recruiting
- NCT07280260 — Clinical Performance of Nobel N1 System · Phase 4 · recruiting
- NCT06773715 — Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain · NA · recruiting
- NCT06874244 — Clinical Evaluation of no Needle Dental Anesthesia Compared to Syringe Anesthesia Delivery · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03100188 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Louisiana State University Health Sciences Center in New Orleans
- Last refreshed: 4 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03100188.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing